Intelligencia was hosted in the AI Industry Connect Talks, for the month of July. The series are organised by SKEL | The AI lab, Institute of Informatics & Telecommunications at NCSR Demokritos and supported by ahedd DIH. The talk was held online on Wednesday 13 July 2022, at 14.00 with invited speakers, Dimitris Skaltsas, Co-founder, Gerry Liaropoulos, Director of Data Science and Violetta Kalathaki, Chief Product Officer at Intelligencia.
Talk title: Drug development and the computational power of AI
Watch the video of the talk below!
Intelligencia is a technology company that focuses on reducing the risk of drug development and enabling external innovation, with the ultimate goal of bringing novel therapies to patients faster. At Intelligencia, curated and proprietary data are combined with the computational power of AI to quantify and improve clinical success and to enhance external innovation.
————————————————
The AI Industry Connect Talks series was launched in March 2021 by SKEL | The Artificial Intelligence Lab, Institute of Informatics & Telecommunications at NCSR Demokritos and is supported by ahedd Digital Innovation Hub. Through this series of talks, we aims to bring AI innovation to the forefront and inform wider audiences of the endless possibilities. Domain professionals tell us how the Industry applies scientific results in real-life.
A Q&A session follows the presentations. The sessions are live-streamed via YouTube.
[See all previous talks in the dedicated webpage here – [Marine Traffic, Contexity, Causaly, Atypon, Lifebit, JADBio, Elsevier, Qualco, Behavioral Signals, SCiFY, Purposeful, Omilia, Pollfish, Accenture]
Application Design & Development Team